NLS COVID-19

AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunization to prevent COVID-19 in individuals 18 years of age and older, including those over 65. The authorization of COVID-19 Vaccine AstraZeneca manufactured by AstraZeneca, and COVISHIELD manufactured by Serum Institute of India (SII), enables global access […]

The Ministry of Healthcare of Republic of Azerbaijan granted an approval to conduct clinical trials of the combined use of the Sputnik V and the COVID 19 vaccine AstraZeneca in Azerbaijan. Previously, the Gamaleya National Center, RDIF, AstraZeneca and R-Pharm signed an agreement to cooperate on COVID-19 vaccine development, which was announced in December 2020. The trial will […]

AstraZeneca and IDT Biologika are exploring options to accelerate output of finished COVID-19 Vaccine AstraZeneca in the second quarter of 2021. AstraZeneca and IDT Biologika also intend to strengthen Europe’s vaccine manufacturing capability with a joint investment to build large additional drug substance capacity for the future. Details of the agreement are to be finalized. […]

AstraZeneca’s COVID-19 vaccine has been granted a conditional marketing authorization (CMA) in the European Union (EU) for active immunization to prevent COVID-19 caused by SARS-CoV-2, in individuals 18 years of age and older. Following review of the application, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency based its positive […]

Scientists have published an action plan for pan-European defense against new SARS-CoV-2 variants in the Lancet. The B.1.1.7 and B1.351 variants, first identified in the UK and South Africa, respectively, have spread to many European countries. Although the biological properties of these variants are yet to be characterized, epidemiological data suggest they have a higher […]

Danish research shows that most of the people hospitalized with COVID-19 had impaired cardiac function. A study that included people with COVID-19 hospitalized in Region Zealand and the Capital Region of Denmark found that as many as 80% had impaired heart function, increasing their risk of serious illness and death. The study also found that […]